Evidence-based practice and health technology assessment: A call for anesthesiologists to engage in knowledge translation;La pratique fondée sur des données probantes et l'évaluation des technologies de la santé: Un appel aux anesthésiologistes pour qu'ils s'impliquent dans le transfert des connaissances

Canadian Journal of Anesthesia

Volumn 58, Issue 4, 2011, Pages 354-363

  Cheng, Davy ^a   Martin, Janet ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; PLACEBO; TRANEXAMIC ACID;

ANESTHESIA; ANESTHESIST; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLEEDING; CLINICAL RESEARCH; EDITORIAL; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; MEDICAL DECISION MAKING; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; TRANSLATIONAL RESEARCH;

ANESTHESIOLOGY; EVIDENCE-BASED PRACTICE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 79953697083     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12630-011-9463-0     Document Type: Editorial

References (19)

1. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312: 71-2.
2. Evidence-Based Medicine Journal. Available from URL: www.ebm.bmj.com (accessed January 2011).
3. JAMA Evidence. User's Guides. Available from URL: www.jamaevidence.com (accessed January 2011).
4. Cohen AM, Stavri PZ, Hersh WR. A categorization and analysis of the criticism of evidence-based medicine. Int J Med Inform 2004; 73: 35-43. (Pubitemid 38229186)
5. Straus SE, McAlister FA. Evidence-based medicine: a commentary on common criticisms. CMAJ 2000; 163: 837-41.
6. Ioannidis JP. Contradicted and initially stronger effects in highly cited clinical research. JAMA 2005; 294: 218-28. (Pubitemid 41043792)
7. Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH. Perioperative beta blockers in patients having noncardiac surgery: a meta-analysis. Lancet 2008; 372: 1962-76. Erratum in: Lancet 2009; 373: 1764.
8. Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 2004; 128: 442-8. (Pubitemid 39194703)
9. Fergusson DA, Hebert PC, Mazer CD, et al. BART Investigators. A comparison of aprotinin, lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-31. Erratum in: N Engl J Med 2010; 363: 1290.
10. Henry D, Carless P, Fergusson D, Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ 2009; 180: 183-93.
11. Velasco M, Perleth M, Drummond M, et al. Best practice in undertaking and reporting health technology assessments. Working Group 4 report. Int J Technol Assess Health Care 2002; 18: 361-422. (Pubitemid 34533752)
12. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116: e418-99.
13. Wijeysundera DN, Beattie WS, Austin PC, Hux JE, Laupacis A. Non-invasive cardiac stress testing before elective major noncardiac surgery: population based cohort study. BMJ 2010; 340: b5526.
14. Grimshaw JM, Thomas RE, MacLennan G, et al. Effeciveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004; 8: iii-iv, 1-72
15. Grimshaw J, McAuley LM, Bero LA, et al. Systematic reviews of the effectiveness of quality improvement strategies and programmes. Qual Saf Health Care 2003; 12: 298-303. (Pubitemid 36981329)
16. Grindrod KA, Patel P, Martin JE. What interventions should pharmacists employ to impact health practitioners' prescribing practices? Ann Pharmacother 2006; 40: 1546-57.
17. Baker R, Camosso-Stefinovic J, Gillies C, et al. Cochrane Database Syst Rev 2010; 17: CD005470.
18. Ontario Ministry of Health and Long-Term Care. Excellent Care for All. Strengthening the Focus on Quality, Value and Evidence-based Care in Ontario. May 3, 2010. Available from URL: http://www.health.gov.on.ca/en/legislation/ excellent-care/excellent-presentation-20100503.pdf (accessed January 2011).
19. McGregor M, Brophy JM. End-user involvement in health technology assessment (HTA) development: a way to increase impact. Int J Technol Assess Health Care 2005; 21: 263-7. (Pubitemid 40656557)